Clinical trial
EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA…
NCT00049231 · Gynecologic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00049231 |
|---|---|
| Title | EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical Cancer |
| Official title | Evaluation of Hypoxia by EF5 (NSC#684681) Binding in Cervix Cancer |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cervical Cancer |
| Intervention type | Drug, Other, Procedure |
| Interventions | EF5, immunohistochemistry staining method, biopsy |
| Start date | Jun 1, 2003 |
| Completion | Aug 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: